SR ONE CAPITAL MANAGEMENT, LLC Insider Trading -- Recent SEC Form 4 Transactions

SR ONE CAPITAL MANAGEMENT, LLC (CIK 1853723) reported 29 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-05-11). Recent activity: Buy ODTX (474,048 shares), Buy ODTX (200,000 shares), Buy ODTX (59,692 shares), Buy ODTX (61,762 shares), Buy ODTX (683,817 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-05-11Odyssey Therapeutics, Inc. (ODTX)10% OwnerBuy474,048$0
2026-05-11Odyssey Therapeutics, Inc. (ODTX)10% OwnerBuy200,000$3.6M
2026-05-11Odyssey Therapeutics, Inc. (ODTX)10% OwnerBuy59,692$0
2026-05-11Odyssey Therapeutics, Inc. (ODTX)10% OwnerBuy61,762$0
2026-05-11Odyssey Therapeutics, Inc. (ODTX)10% OwnerBuy683,817$0
2026-05-11Odyssey Therapeutics, Inc. (ODTX)10% OwnerBuy191,541$0
2026-05-11Odyssey Therapeutics, Inc. (ODTX)10% OwnerSell1,065$19,170
2026-05-11Odyssey Therapeutics, Inc. (ODTX)10% OwnerBuy139,366$0
2026-05-11Odyssey Therapeutics, Inc. (ODTX)10% OwnerBuy118,512$0
2026-05-11Odyssey Therapeutics, Inc. (ODTX)10% OwnerBuy255,823$0
2026-05-11Odyssey Therapeutics, Inc. (ODTX)10% OwnerBuy204,658$0
2026-05-11Odyssey Therapeutics, Inc. (ODTX)10% OwnerBuy20,582$0
2026-05-11Odyssey Therapeutics, Inc. (ODTX)10% OwnerBuy166,168$0
2026-05-11Odyssey Therapeutics, Inc. (ODTX)10% OwnerBuy49,850$0
2026-05-11Odyssey Therapeutics, Inc. (ODTX)10% OwnerSell277$4,986
2026-05-11Odyssey Therapeutics, Inc. (ODTX)10% OwnerBuy133,333$2.4M
2026-05-11Odyssey Therapeutics, Inc. (ODTX)10% OwnerBuy463,106$0
2026-05-11Odyssey Therapeutics, Inc. (ODTX)10% OwnerBuy273,527$0
2026-05-11Odyssey Therapeutics, Inc. (ODTX)10% OwnerBuy78,656$0
2026-05-11Odyssey Therapeutics, Inc. (ODTX)10% OwnerSell438$7,884
2026-05-11Odyssey Therapeutics, Inc. (ODTX)10% OwnerBuy222,222$4.0M
2026-05-01Avalyn Pharma Inc. (AVLN)10% OwnerBuy1.4M$0
2026-05-01Avalyn Pharma Inc. (AVLN)10% OwnerBuy489,486$0
2026-05-01Avalyn Pharma Inc. (AVLN)10% OwnerBuy277,778$5.0M
2026-05-01Avalyn Pharma Inc. (AVLN)10% OwnerBuy354,824$0

Source: SEC Form 4 filings · as of 2026-05-11